- ￥2600
- AntibodySystem
- VHC43601
- 2025年07月04日
- ELISA, FCM, Neutralization, WB
- Mouse
- Human
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 抗体名：
InVivoMAb Anti-Human C1S Antibody (TNT003)
- 抗体英文名：
InVivoMAb Anti-Human C1S Antibody (TNT003)
- 浓度：
1 mg/ml
- 应用范围：
ELISA, FCM, Neutralization, WB
- 宿主：
Mouse
- 适应物种：
Human
- 保质期：
1 year
- 级别：
科研级
- 库存：
999
- 供应商：
AntibodySystem
- 克隆性：
Monoclonal
- 亚型：
IgG2a, kappa
- 规格：
100ug
| 宿主 | Mouse |
| 种属反应性 | Human |
| 状态 | Liquid |
| 保存溶液 | 0.01M PBS, pH 7.4. |
| 浓度 | 1 mg/ml |
| 纯度 | >95% as determined by SDS-PAGE. |
| 克隆类型 | Monoclonal |
| 同种型 | IgG2a, kappa |
| 应用 | ELISA, FCM, Neutralization, WB |
| 靶标 | C1 esterase, Complement C1s subcomponent, C1S, Complement component 1 subcomponent s |
| 纯化方式 | Protein A/G purified from cell culture supernatant. |
| 内毒素水平 | Please contact with the lab for this information. |
| Accession号 | P09871 |
| 稳定性和存储 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| 克隆号 | TNT003 |
| 备注 | For research use only. Not suitable for clinical or therapeutic use. |
Our products are designed for various research areas, supporting studies on 48 types of viruses, superbugs, parasites, cancer, Alzheimer's disease, Parkinson's disease, allergic responses, immune suppression, and immune activation.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验associates with the recognition protein C1q. The C1 complex circulates in serum as a zymogen and is activated upon binding of C1q to appropriate targets, such as antigen–antibody complexes. This property is used for the purification of C1r and C1s from human
【翻译】Development trends for monoclonal antibody cancer therapeutics
). However, since 2000, humanized and human mAbs have been entering clinical study at approximately the same rate (4.3 versus 4.5 mAbs per year, respectively). Figure 1 | Categories of monoclonal antibody cancer therapeutics entering clinical study during 1980–1989
。 F、利用蛋白芯片做相关研究还需要的其他试剂（R&D Systems不提供的） 四、R&D Systems公司蛋白芯片试验操作步骤介绍 1、试验操作步骤流程图 2、以Human Phospho-Kinase Array（ARY003）蛋白芯片为例详细说明 操作步骤 A、详细试验操作步骤： B、试验结果 C注意事项： Human Phospho-Kinase Array（ARY003 ）蛋白芯片为何芯片为2个部分? 原因： a、以优化敏感度，降低交叉反应，故将芯片和检测
技术资料暂无技术资料 索取技术资料
